Nektar Therapeutics
NKTR
trading on NASDAQ
since 1994
$24.97
(Δ 1.43%)
+$0.35 since open
Nektar Therapeutics is a biopharmaceutical company dedicated to advancing innovative medicines through its proprietary PEGylation platform, focusing on treatments for chronic pain and oncology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $19.92 | $27.68 | $16.56 | $108.31M | 37.17M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.24 | n/a | 503.52 | -425.76% | -486.44% | 0% |